Intestinal perforation secondary to intestinal diffuse large b-cell lymphoma in a patient with coeliac disease

Gastroenterol Hepatol. 2018 Oct;41(8):503-504. doi: 10.1016/j.gastrohep.2017.09.001. Epub 2017 Oct 18.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Celiac Disease / complications*
  • Celiac Disease / diet therapy
  • Colectomy
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Diet, Gluten-Free
  • Disease Susceptibility
  • Down Syndrome / complications
  • Doxorubicin / administration & dosage
  • Humans
  • Intestinal Perforation / etiology*
  • Intestinal Perforation / surgery
  • Jejunal Diseases / etiology*
  • Jejunal Diseases / surgery
  • Jejunal Neoplasms / complications
  • Jejunal Neoplasms / drug therapy
  • Jejunal Neoplasms / prevention & control
  • Jejunal Neoplasms / surgery
  • Lymphoma, Large B-Cell, Diffuse / complications*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / prevention & control
  • Lymphoma, Large B-Cell, Diffuse / surgery
  • Male
  • Positron Emission Tomography Computed Tomography
  • Prednisone / administration & dosage
  • Rituximab / administration & dosage
  • Tomography, X-Ray Computed
  • Vincristine / administration & dosage

Substances

  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol